Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc. 1993;68:988–1001.
Article CAS PubMed Google Scholar
Jänig W. Integrative action of the autonomic nervous system: neurobiology of homeostasis. Cambridge: Cambridge University Press; 2006.
Beissner F, Meissner K, Bär KJ, Napadow V. The autonomic brain: an activation likelihood estimation meta-analysis for central processing of autonomic function. J Neurosci. 2013;33:10503–11.
Article CAS PubMed PubMed Central Google Scholar
Engelhardt E, Laks J. Alzheimer disease neuropathology: understanding autonomic dysfunction. Dement Neuropsychol. 2008;2:183–91.
Article PubMed PubMed Central Google Scholar
Collins O, Dillon S, Finucane C, Lawlor B, Kenny RA. Parasympathetic autonomic dysfunction is common in mild cognitive impairment. Neurobiol Aging. 2012;33:2324–33.
Tulbă D, Cozma L, Popescu BO, Davidescu EI. Dysautonomia in Alzheimer’s disease. Med (Kaunas). 2020;56.
Jensen-Dahm C, et al. Autonomic dysfunction in patients with mild to moderate Alzheimer’s disease. J Alzheimers Dis. 2015;47:681–9.
Royall DR, Gao JH, Kellogg DL Jr. Insular Alzheimer’s disease pathology as a cause of age-related autonomic dysfunction and mortality in the non-demented elderly. Med Hypotheses. 2006;67:747–58.
Valenza G, et al. The central autonomic network at rest: uncovering functional MRI correlates of time-varying autonomic outflow. NeuroImage. 2019;197:383–90.
Article CAS PubMed Google Scholar
Ding K, et al. Central autonomic network functional connectivity: correlation with baroreflex function and cardiovascular variability in older adults. Brain Struct Funct. 2020;225:1575–85.
Article PubMed PubMed Central Google Scholar
Nair SS et al. Investigation of autonomic dysfunction in Alzheimer’s disease-a computational model-based approach. Brain Sci. 2023;13.
Nonogaki Z, Umegaki H, Makino T, Suzuki Y, Kuzuya M. Relationship between cardiac autonomic function and cognitive function in Alzheimer’s disease. Geriatr Gerontol Int. 2017;17:92–8.
Brier MR, Thomas JB, Ances BM. Network dysfunction in Alzheimer’s disease: refining the disconnection hypothesis. Brain Connect. 2014;4:299–311.
Article PubMed PubMed Central Google Scholar
Sheline YI, et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry. 2010;67:584–7.
Article CAS PubMed Google Scholar
Neufang S, et al. Disconnection of frontal and parietal areas contributes to impaired attention in very early Alzheimer’s disease. J Alzheimers Dis. 2011;25:309–21.
Article CAS PubMed Google Scholar
Allen G, et al. Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol. 2007;64:1482–7.
Wang L, et al. Changes in hippocampal connectivity in the early stages of Alzheimer’s disease: evidence from resting state fMRI. NeuroImage. 2006;31:496–504.
Dautricourt S, et al. Longitudinal changes in hippocampal network connectivity in Alzheimer’s disease. Ann Neurol. 2021;90:391–406.
Article CAS PubMed PubMed Central Google Scholar
Johnson-Greene D, Dementia Rating Scale-2 (DRS-2) By, Jurica PJ, Leitten CL. and S. Mattis: psychological assessment resources, 2001. Arch Clin Neuropsychol. 2004;19:145–147.
Kapoor A et al. Increased levels of circulating angiogenic cells and signaling proteins in older adults with cerebral small vessel disease. Front Aging Neurosci. 2021;13.
Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125–41.
Nieto-Castanon A. Handbook of functional connectivity magnetic resonance imaging methods in CONN. 2020.
Grothe MJ, et al. Associations of fully automated CSF and novel plasma biomarkers with Alzheimer disease neuropathology at autopsy. Neurology. 2021;97:e1229–42.
Article CAS PubMed PubMed Central Google Scholar
Hayes AF. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. Guilford Press, New York, NY, US. 2013, pp. xvii, 507-xvii, 507.
Korthauer K, et al. A practical guide to methods controlling false discoveries in computational biology. Genome Biol. 2019;20:118.
Article PubMed PubMed Central Google Scholar
Mayer CA, et al. Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PLoS ONE. 2013;8:e62101.
Article CAS PubMed PubMed Central Google Scholar
Abdelhak A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Reviews Neurol. 2022;18:158–72.
Amalia L. Glial fibrillary acidic protein (GFAP): Neuroinflammation Biomarker in Acute ischemic stroke. J Inflamm Res. 2021;14:7501–6.
Article CAS PubMed PubMed Central Google Scholar
Benedet AL, et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol. 2021;78:1471–83.
Kim KY, Shin KY, Chang K-A. GFAP as a potential biomarker for Alzheimer’s disease: a systematic review and meta-analysis. Cells. 2023. https://doi.org/10.3390/cells12091309.
Article PubMed PubMed Central Google Scholar
Chatterjee P, et al. Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer’s disease: associations with Aβ-PET, neurodegeneration, and cognition. Alzheimer’s Dement. 2023;19:2790–804.
Pereira JB, et al. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease. Brain. 2021;144:3505–16.
Article PubMed PubMed Central Google Scholar
Giacomucci G, et al. Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in subjective cognitive decline and mild cognitive impairment. J Neurol. 2022;269:4270–80.
Article CAS PubMed PubMed Central Google Scholar
Lewczuk P, et al. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease. Alzheimers Res Ther. 2018;10:71.
Article PubMed PubMed Central Google Scholar
de Heus RAA, Olde Rikkert MGM, Tully PJ, Lawlor BA, Claassen J. Blood pressure variability and progression of clinical Alzheimer disease. Hypertension. 2019;74:1172–80.
Jarczok MN, et al. Heart rate variability in the prediction of mortality: a systematic review and meta-analysis of healthy and patient populations. Neurosci Biobehav Rev. 2022;143:104907.
Rovere MTL, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478–84.
deBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol Heart Circ Physiol. 1987;253:H680–9.
留言 (0)